Brief: Black Diamond Therapeutics Reports Second Quarter 2022 Financial Results

Black Diamond Therapeutics

09/08/2022 15:20

Aug 9 (Reuters) - Black Diamond Therapeutics Inc  BDTX.O :
    * BLACK DIAMOND THERAPEUTICS REPORTS SECOND QUARTER 2022
FINANCIAL
RESULTS AND PROVIDES CORPORATE UPDATE
    * CASH, CASH EQUIVALENTS AND INVESTMENTS OF APPROXIMATELY
$160.9
MILLION AS OF JUNE 30, 2022
    * CASH EXPECTED TO BE SUFFICIENT TO FUND OPERATIONS INTO Q3
OF
2024
    * NET LOSS FOR Q2 OF 2022 WAS $22.9 MILLION, AS COMPARED TO
$34.4
MILLION FOR SAME PERIOD IN 2021
    * Q3 EARNINGS PER SHARE VIEW $-0.69 -- REFINITIV IBES DATA

Source text for Eikon:  ID:nGNX7slt9D 
Further company coverage:  BDTX.O 

 ((reuters.briefs@thomsonreuters.com;))